Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Prepaid Assets: 2016-2025

Historic Prepaid Assets for UroGen Pharma (URGN) over the last 9 years, with Sep 2025 value amounting to $12.1 million.

  • UroGen Pharma's Prepaid Assets fell 13.74% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year decrease of 13.74%. This contributed to the annual value of $8.8 million for FY2024, which is 13.97% down from last year.
  • As of Q3 2025, UroGen Pharma's Prepaid Assets stood at $12.1 million, which was up 0.56% from $12.1 million recorded in Q2 2025.
  • Over the past 5 years, UroGen Pharma's Prepaid Assets peaked at $16.0 million during Q3 2023, and registered a low of $5.3 million during Q2 2021.
  • Its 3-year average for Prepaid Assets is $12.2 million, with a median of $12.1 million in 2023.
  • In the last 5 years, UroGen Pharma's Prepaid Assets spiked by 306.96% in 2021 and then fell by 13.97% in 2024.
  • Over the past 5 years, UroGen Pharma's Prepaid Assets (Quarterly) stood at $7.5 million in 2021, then soared by 48.49% to $11.1 million in 2022, then fell by 7.39% to $10.3 million in 2023, then decreased by 13.97% to $8.8 million in 2024, then dropped by 13.74% to $12.1 million in 2025.
  • Its Prepaid Assets was $12.1 million in Q3 2025, compared to $12.1 million in Q2 2025 and $13.0 million in Q1 2025.